[English] 日本語
Yorodumi
- EMDB-71064: Cryo-EM structure of S. Mansoni p97 bound to compound 739 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: EMDB / ID: EMD-71064
TitleCryo-EM structure of S. Mansoni p97 bound to compound 739
Map datastructure of S. Mansoni p97 bound to compound 739
Sample
  • Complex: Hexamer of p97 conjugated to inhibitor 739
    • Protein or peptide: vesicle-fusing ATPase
  • Ligand: (2E)-3-(pyridin-4-yl)-N-[2-(pyridin-2-yl)-1,3-benzoxazol-5-yl]prop-2-enamide
KeywordsAAA-ATPase / Endoplasmic Reticulum / Hexamer / Inhibitor / CHAPERONE
Function / homology
Function and homology information


mitotic spindle disassembly / VCP-NPL4-UFD1 AAA ATPase complex / vesicle-fusing ATPase / retrograde protein transport, ER to cytosol / polyubiquitin modification-dependent protein binding / autophagosome maturation / ATP hydrolysis activity / ATP binding / nucleus / cytosol
Similarity search - Function
AAA ATPase, CDC48 family / Cell division protein 48 (CDC48), N-terminal domain / : / CDC48, N-terminal subdomain / Cell division protein 48 (CDC48) N-terminal domain / CDC48, domain 2 / Cell division protein 48 (CDC48), domain 2 / Cell division protein 48 (CDC48) domain 2 / CDC48 domain 2-like superfamily / Aspartate decarboxylase-like domain superfamily ...AAA ATPase, CDC48 family / Cell division protein 48 (CDC48), N-terminal domain / : / CDC48, N-terminal subdomain / Cell division protein 48 (CDC48) N-terminal domain / CDC48, domain 2 / Cell division protein 48 (CDC48), domain 2 / Cell division protein 48 (CDC48) domain 2 / CDC48 domain 2-like superfamily / Aspartate decarboxylase-like domain superfamily / AAA ATPase, AAA+ lid domain / AAA+ lid domain / ATPase, AAA-type, conserved site / AAA-protein family signature. / ATPase family associated with various cellular activities (AAA) / ATPase, AAA-type, core / ATPases associated with a variety of cellular activities / AAA+ ATPase domain / P-loop containing nucleoside triphosphate hydrolase
Similarity search - Domain/homology
vesicle-fusing ATPase
Similarity search - Component
Biological speciesSchistosoma mansoni (invertebrata)
Methodsingle particle reconstruction / cryo EM / Resolution: 3.06 Å
AuthorsStephens DR / Han Y / Chen Z / Liang J / Ready J / Collins JJ / Fung HYJ
Funding support United States, 5 items
OrganizationGrant numberCountry
Cancer Prevention and Research Institute of Texas (CPRIT)RP220582 United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)R01AI167967 United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)R01AI150776 United States
Welch FoundationI-1948-20240404 United States
Howard Hughes Medical Institute (HHMI) United States
CitationJournal: Proc Natl Acad Sci U S A / Year: 2025
Title: A genome-scale drug discovery pipeline uncovers therapeutic targets and a unique p97 allosteric binding site in .
Authors: Dylon R Stephens / Ho Yee Joyce Fung / Yan Han / Jue Liang / Zhe Chen / Joseph Ready / James J Collins /
Abstract: Schistosomes are parasitic flatworms that infect more than 200 million people globally. However, there is a shortage of molecular tools that enable the discovery of potential drug targets within ...Schistosomes are parasitic flatworms that infect more than 200 million people globally. However, there is a shortage of molecular tools that enable the discovery of potential drug targets within schistosomes. Thus, praziquantel has remained the frontline treatment for schistosomiasis despite known liabilities. Here, we have conducted a genome-wide study in using the human druggable genome as a bioinformatic template to identify essential genes within schistosomes bearing similarity to catalogued drug targets. Then, we assessed these candidate targets in silico using a set of unbiased criteria to determine which possess ideal characteristics for a ready-made drug discovery campaign. Following this prioritization, we pursued a parasite p97 ortholog as a bona-fide drug target for the development of therapeutics to treat schistosomiasis. From this effort, we identified a covalent inhibitor series that kills schistosomes through an on-target killing mechanism by disrupting the ubiquitin proteasome system. Fascinatingly, these inhibitors induce a conformational change in the conserved D2 domain P-loop of schistosome p97 upon modification of Cys519. This conformational change reveals an allosteric binding site adjacent to the D2 domain active site reminiscent of the "DFG" flip in protein kinases. This allosteric binding site can potentially be utilized to generate new classes of species-selective p97 inhibitors. Furthermore, these studies provide a resource for the development of alternative therapeutics for schistosomiasis and a workflow to identify potential drug targets in similar systems with few available molecular tools.
History
DepositionJun 6, 2025-
Header (metadata) releaseAug 13, 2025-
Map releaseAug 13, 2025-
UpdateSep 10, 2025-
Current statusSep 10, 2025Processing site: RCSB / Status: Released

-
Structure visualization

Supplemental images

emd_71064.png

Downloads & links

-
Map

FileDownload / File: emd_71064.map.gz / Format: CCP4 / Size: 343 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES)
Annotationstructure of S. Mansoni p97 bound to compound 739
Projections & slices

Image control

Size
Brightness
Contrast
Others
AxesZ (Sec.)Y (Row.)X (Col.)
0.74 Å/pix.
x 448 pix.
= 330.624 Å		0.74 Å/pix.
x 448 pix.
= 330.624 Å		0.74 Å/pix.
x 448 pix.
= 330.624 Å

Surface

Projections

Slices (1/3)

Slices (1/2)

Slices (2/3)

Images are generated by Spider.

Voxel sizeX=Y=Z: 0.738 Å
Density

Histogram

Histogram (log scale)
Contour LevelBy AUTHOR: 0.06
Minimum - Maximum-0.16404785 - 0.34170598
Average (Standard dev.)0.00020318084 (±0.008700134)
SymmetrySpace group: 1
Details

EMDB XML:

Map geometry
Axis orderXYZ
Origin000
Dimensions448448448
Spacing448448448
CellA=B=C: 330.624 Å
α=β=γ: 90.0 °

-
Supplemental data

-
Half map: Half Map B

Fileemd_71064_half_map_1.map
AnnotationHalf Map B
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

Histogram

Histogram (log scale)

-
Half map: Half Map A

Fileemd_71064_half_map_2.map
AnnotationHalf Map A
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

Histogram

Histogram (log scale)

-
Sample components

-
Entire : Hexamer of p97 conjugated to inhibitor 739

EntireName: Hexamer of p97 conjugated to inhibitor 739
Components
  • Complex: Hexamer of p97 conjugated to inhibitor 739
    • Protein or peptide: vesicle-fusing ATPase
  • Ligand: (2E)-3-(pyridin-4-yl)-N-[2-(pyridin-2-yl)-1,3-benzoxazol-5-yl]prop-2-enamide

-
Supramolecule #1: Hexamer of p97 conjugated to inhibitor 739

SupramoleculeName: Hexamer of p97 conjugated to inhibitor 739 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1
Source (natural)Organism: Schistosoma mansoni (invertebrata)

-
Macromolecule #1: vesicle-fusing ATPase

MacromoleculeName: vesicle-fusing ATPase / type: protein_or_peptide / ID: 1 / Details: First 37 residues are expression tags. / Number of copies: 6 / Enantiomer: LEVO / EC number: vesicle-fusing ATPase
Source (natural)Organism: Schistosoma mansoni (invertebrata)
Molecular weightTheoretical: 92.755594 KDa
Recombinant expressionOrganism: Escherichia coli BL21(DE3) (bacteria)
SequenceString: MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFMCAL NANPSNDPSS GEKVKFHRLI VDEPVKDDNS VVYLSQAKMD SMNLFRGDT VLVKGKKRKE TVCVAIVDES CPDDKIRLNR CIRSNLRVKP GDIISIKSLP DILYGKRIHV LPIDDTIVGL T GNLYEAFL ...String:
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFMCAL NANPSNDPSS GEKVKFHRLI VDEPVKDDNS VVYLSQAKMD SMNLFRGDT VLVKGKKRKE TVCVAIVDES CPDDKIRLNR CIRSNLRVKP GDIISIKSLP DILYGKRIHV LPIDDTIVGL T GNLYEAFL KPYFLAAYRP VHKGDIFIVR GGMRAVEFKV IETDPSPYCI VSPDTTIHTE GDPVKREDEE EKLNEIGYDD IG GCRKQLA QIKEMVELPL RHPQLFKAIG VKPPRGILLY GPPGTGKTLV ARAVANESGS FFFLINGPEI MSKLAGESES NLR KAFEEA EKNAPAIIFI DELDAIAPKR EKTHGEVERR IVSQLLTLMD GLKQRSHVIV MAATNRPNSV DPALRRFGRF DREI EIGIP DSIGRLEILR IHTRNIRLAE DVELEKIANE AHGHVGADLA SLCSEAALQQ IRNKMNLIDL EDDTIDAEVL NSLAV TMDD FRWALGKSNP SALRETTVEV PNVTWDDIGG LENVKRELQE LVQYPVEHPD KFLKFGMTPS KGVLFYGPPG CGKTLL AKA IANECQANFI SIKGPELLTM WFGESEANVR DIFDKARQAA PCVLFFDELD SIAKARGGSV GDAGGAADRV INQLLTE MD GMSAKKNVFI IGATNRPDII DGAILRPGRL DQLIYIPLPD EASRVNILKA NLRKSPIARD VDINFLAKAT QGFSGADL T EICQRACKQA IRESIEAEIR AESEKKNKPN AMEDDFDPVP EITRRHFEEA MRFARRSVTE NDVRKYEMFA QTLQQSRGI GNNFRFPGSD GSGIPTSTGG QGGGGSVYGS QNDAEDLYN

UniProtKB: vesicle-fusing ATPase

-
Macromolecule #2: (2E)-3-(pyridin-4-yl)-N-[2-(pyridin-2-yl)-1,3-benzoxazol-5-yl]pro...

MacromoleculeName: (2E)-3-(pyridin-4-yl)-N-[2-(pyridin-2-yl)-1,3-benzoxazol-5-yl]prop-2-enamide
type: ligand / ID: 2 / Number of copies: 6 / Formula: A1CGC
Molecular weightTheoretical: 342.351 Da

-
Experimental details

-
Structure determination

Methodcryo EM
Processingsingle particle reconstruction
Aggregation stateparticle

-
Sample preparation

Concentration1 mg/mL
BufferpH: 7.4
Details: 20mM Tris (pH 7.4), 180mM NaCl, 5mM MgCl2, and 1mM tris(2-carboxyethyl)phosphine (TCEP)
GridModel: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 80 sec.
VitrificationCryogen name: ETHANE / Instrument: FEI VITROBOT MARK IV

-
Electron microscopy

MicroscopeTFS KRIOS
Specialist opticsEnergy filter - Name: TFS Selectris / Energy filter - Slit width: 10 eV
Image recordingFilm or detector model: TFS FALCON 4i (4k x 4k) / Average electron dose: 60.0 e/Å2
Electron beamAcceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN
Electron opticsIllumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.2 µm / Nominal defocus min: 0.9 µm
Experimental equipment
Model: Titan Krios / Image courtesy: FEI Company

+
Image processing

Particle selectionNumber selected: 2812039
Details: Template pick with templates generated used the CB-5083-bound map
CTF correctionSoftware - Name: cryoSPARC / Type: PHASE FLIPPING AND AMPLITUDE CORRECTION
Startup modelType of model: EMDB MAP
EMDB ID:

70961


Details: CB-5083-bound map
Final reconstructionApplied symmetry - Point group: C6 (6 fold cyclic) / Resolution.type: BY AUTHOR / Resolution: 3.06 Å / Resolution method: FSC 0.143 CUT-OFF / Software - Name: cryoSPARC
Details: Non-uniform refinement with C6 symmetry applied, with global and CTF refinements. Unsharpened map was used for modeling
Number images used: 101602
Initial angle assignmentType: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC
Final angle assignmentType: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC
Final 3D classificationNumber classes: 3 / Software - Name: cryoSPARC / Details: With C6 symmetry
FSC plot (resolution estimation)

-
Atomic model buiding 1

Initial modelPDB ID:

9p00


Chain - Source name: PDB / Chain - Initial model type: experimental model
DetailsApo structure was docked as initial model, then went through multiple rounds of manual fitting in coot and refinement in Phenix.
Output model

PDB-9p02:
Cryo-EM structure of S. Mansoni p97 bound to compound 739

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more